HOME >> BIOLOGY >> NEWS
Heart-stopping antibodies

The immune system uses antibodies to target foreign, "non-self" proteins and cells. Autoimmune antibodies, by contrast, attack the body's own cells, and those circulating in women with lupus and other autoimmune diseases can also cross the placenta and cause congenital heart block in the fetus. Scientists in Sweden now show how these antibodies cause heart cells to become paralyzed and eventually die, according to a study in the January 3rd issue of The Journal of Experimental Medicine.

Autoantibodies had been implicated as a cause of congenital heart block in the past, but nobody knew how they were working. This study shows that the antibodies bind to heart cells and disrupt the proper fluctuations of calcium ions that allow the cell to contract, causing a toxic build up of calcium which triggers the death of the cell.

It is not known what protein on the cell surface these antibodies are binding to, nor is it clear how these antibodies are disrupting the calcium fluctuations that are required for the heart cells to contract. The authors are actively searching for the binding target of these antibodies. Meanwhile, they hope that their success in narrowing down the identity of the responsible antibodies will provide a new way to identify women who are most at risk for having children with congenital heart block.


'"/>

Contact: Nickey Henry
henryn@rockefeller.edu
212-327-8366
Journal of Experimental Medicine
3-Jan-2005


Page: 1

Related biology news :

1. Avian influenza survivors antibodies effective at neutralising H5N1 strain
2. Immune antibodies penetrate neurons to clear Alzheimers-linked amyloid
3. Cheaper, better disease treatments expected from faster approach to developing antibodies
4. Elevated autoantibodies linked to preeclampsia
5. Report calls for improved monoclonal antibodies against solid tumors
6. Biolex reports potential for more potent, efficacious antibodies in Nature Biotechnology
7. Horse antibodies against the bird flu virus H5N1 are effective as treatment in mice
8. Data published in PNAS show antibodies can be made 10 times more toxic to cancer cells
9. Human trial proves ricin vaccine safe, induces neutralizing antibodies; further tests planned
10. GlycoFi announces the first production of antibodies with human glycosylation in yeast
11. Faster method to create antibodies for disease research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 02, 2020 , ... Dutch ... the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for SARS-CoV-2 ... The article, titled "Ultra-fast one-step RT-PCR protocol for the detection of SARS-CoV-2," ...
(Date:6/28/2020)... Fla. (PRWEB) , ... June 25, 2020 , ... In ... focus on innovations in accelerated Point of Care Testing solutions (POCT). Check local listings ... Samples are collected at medical offices and are shipped to labs throughout the country. ...
(Date:6/23/2020)... ... ... The field of quantitation of large molecules or proteins has been around ... the use of mass spectrometry in this field has gained a lot of momentum ... choose which approach to use (LBA or MS)?” In many cases, either technology ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... , ... eSource has long been touted as the solution to high data ... the reasons it did not take off as quickly as people initially expected, and ... moving towards capturing data electronically for clinical trials and then repurposing it for downstream ...
(Date:7/22/2020)... ... ... Join experts from Reed Tech , Gary Saner, Sr. Manager, Information Solutions Life ... webinar on Thursday, August 13, 2020 at 11am EDT (4pm BST/UK). , The ... medical devices, the NMPA has departments dealing with medical device registration (pre-market approvals) and ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... aid in the early detection and prevention of high-burden diseases, and Centric Consulting, ... hospitals and healthcare organizations to utilize existing data in order to identify and ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... of Technology (MIT) has expanded the company’s exclusive license to include clinical ... the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ ...
Breaking Biology Technology:
Cached News: